title: LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment.
authors.forename: L
authors.initials: L
authors.lastname: Muratori
authors.forename: D
authors.initials: D
authors.lastname: Zauli
authors.forename: F
authors.initials: F
authors.lastname: Giostra
authors.forename: G
authors.initials: G
authors.lastname: Ballardini
authors.forename: M
authors.initials: M
authors.lastname: Lenzi
authors.forename: F
authors.initials: F
authors.lastname: Cassani
authors.forename: F B
authors.initials: FB
authors.lastname: Bianchi
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D002908:Chronic Disease; D015803:HLA-DR3 Antigen / Q000097:blood*; D006526:Hepatitis C / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male
chemical_list: D001323:Autoantibodies; D015803:HLA-DR3 Antigen; C060729:anti-liver kidney microsome antibody; D007372:Interferons